Market Share of Global Metastatic Cancer Treatment Industry
The metastatic cancer treatment market is competitive in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market share and are well known. Some of the major players include Bristol Myers Squibb Company, Celgene, Roche, Merck and Co., Johnson & Johnson Services Inc, GlaxoSmithKline Plc, AstraZeneca, Lilly, Novartis AG, Pfizer Inc, AbbVie Inc, and Amgen Inc, among others.
Metastatic Cancer Treatment Market Leaders
Bristol Myers Squibb Company
Merck and Co Inc.
Johnson & Johnson Services Inc
Novartis AG
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
